ATLAS / Macro Radar / Reporting / INTS

INTENSITY THERAPEUTICS, INC. (INTS) reporting calendar

INTENSITY THERAPEUTICS, INC. files periodic reports with the SEC as INTS on Nasdaq. Atlas tracks 12 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
17 Jul 2026 – 3 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
12

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 41 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open INTS market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001567264-26-000046
10-K31 Dec 202527 Mar 202686 days0001567264-26-000024
10-Q30 Sep 20256 Nov 202537 days0001567264-25-000103
10-Q30 Jun 20257 Aug 202538 days0001567264-25-000077
10-Q31 Mar 202513 May 202543 days0001567264-25-000039
10-K31 Dec 202413 Mar 202572 days0001567264-25-000010
10-Q30 Sep 202413 Nov 202444 days0001567264-24-000052
10-Q30 Jun 20248 Aug 202439 days0001567264-24-000041
10-Q31 Mar 20249 May 202439 days0001567264-24-000010
10-K31 Dec 202314 Mar 202474 days0001628280-24-011207
10-Q30 Sep 202313 Nov 202344 days0001213900-23-085791
10-Q30 Jun 202314 Aug 202345 days0001213900-23-066740

Source: SEC EDGAR company submissions for CIK 0001567264. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.